UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Holdings History for LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0

Investment type: Debt / NOTE 5.250%12/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Jun 2020		0%	$6,513,885	10,500,000	0		62.04% ^*	Q2 2020
31 Mar 2020	0%	0%	$5,701,605	10,500,000	0		54.3%	Q1 2020
31 Dec 2019	0.01%	0%	$8,531,250	10,500,000	0		81.25%	Q4 2019
30 Sep 2019	0.01%	0%	$7,593,600	10,500,000	0		72.32%	Q3 2019
30 Jun 2019	0.01%	0%	$11,434,500	10,500,000	0		108.9%	Q2 2019
31 Mar 2019	0.01%	0%	$10,735,200	10,500,000	0		102.24%	Q1 2019
31 Dec 2018	0.01%	0%	$11,677,785	10,500,000	0		111.22%	Q4 2018
30 Sep 2018	0.01%	0%	$15,604,575	10,500,000	0		148.62%	Q3 2018
30 Jun 2018	0.01%	0%	$16,969,471	10,500,000	0		161.61%	Q2 2018
31 Mar 2018	0.01%	+0%	$13,640,235	10,500,000	+500,000	+5%	129.91%	Q1 2018
31 Dec 2017	0.01%	0%	$13,987,001	10,000,000	0		139.87%	Q4 2017
30 Sep 2017	0.01%	0%	$16,296,500	10,000,000	0		162.97%	Q3 2017
30 Jun 2017	0.02%	+0%	$20,797,200	10,000,000	+1,000,000	+11%	207.97%	Q2 2017
31 Mar 2017	0.02%	+0%	$16,750,080	9,000,000	+1,000,000	+12%	186.11%	Q1 2017
31 Dec 2016	0.02%	+0%	$14,305,000	8,000,000	+1,000,000	+14%	178.81%	Q4 2016
30 Sep 2016	0.02%	-0%	$15,873,000	7,000,000	-2,000,000	-22%	226.76%	Q3 2016
30 Jun 2016	0.02%	-0.01%	$16,795,000	9,000,000	-3,000,000	-25%	186.61%	Q2 2016
31 Mar 2016	0.02%	+0%	$19,225,000	12,000,000	+1,000,000	+9.1%	160.21%	Q1 2016
31 Dec 2015	0.02%	+0.02%	$19,154,000	11,000,000	+11,000,000	NEW	174.13%	Q4 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.